Oxford Asset Management’s Terns Pharmaceuticals TERN Stock Holding History

Oxford Asset Management’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-39,090	Closed	-$2.06M	–	621
2026 Q1	$2.06M	Buy	+39,090	New	+$1.61M	0.83%	16
2025 Q2	–	Sell	-33,027	Closed	-$91.2K	–	760
2025 Q1	$91.2K	Buy	33,027 +17,571	+114%	+$71.8K	0.04%	425
2024 Q4	$85.6K	Buy	+15,456	New	+$105K	0.04%	403
2024 Q3	–	Sell	-14,689	Closed	-$100K	–	446
2024 Q2	$100K	Buy	+14,689	New	+$89K	0.1%	235

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Oxford Asset Management's TERN Position: Q2 2026 in Review

Oxford Asset Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 39,090 shares — an estimated $2.06M sold.

Oxford Asset Management first reported a position in TERN in Q2 2024 and held it in 4 quarters. The position peaked at $2.06M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Oxford Asset Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Oxford Asset Management sold 39,090 Terns Pharmaceuticals shares in Q2 2026, an estimated $2.06M.
Oxford Asset Management first reported a position in Terns Pharmaceuticals in Q2 2024 and held it in 4 quarters.
Oxford Asset Management's Terns Pharmaceuticals position peaked at $2.06M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.